These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Proteostasis as a therapeutic target in glomerular injury associated with mutant α-actinin-4. Yee A; Papillon J; Guillemette J; Kaufman DR; Kennedy CRJ; Cybulsky AV Am J Physiol Renal Physiol; 2018 Oct; 315(4):F954-F966. PubMed ID: 29873512 [TBL] [Abstract][Full Text] [Related]
5. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4. Michaud JL; Lemieux LI; Dubé M; Vanderhyden BC; Robertson SJ; Kennedy CR J Am Soc Nephrol; 2003 May; 14(5):1200-11. PubMed ID: 12707390 [TBL] [Abstract][Full Text] [Related]
6. Disease-causing mutation in α-actinin-4 promotes podocyte detachment through maladaptation to periodic stretch. Feng D; Notbohm J; Benjamin A; He S; Wang M; Ang LH; Bantawa M; Bouzid M; Del Gado E; Krishnan R; Pollak MR Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1517-1522. PubMed ID: 29378953 [TBL] [Abstract][Full Text] [Related]
7. Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. Khurana S; Chakraborty S; Lam M; Liu Y; Su YT; Zhao X; Saleem MA; Mathieson PW; Bruggeman LA; Kao HY J Biol Chem; 2012 Apr; 287(15):12027-35. PubMed ID: 22351778 [TBL] [Abstract][Full Text] [Related]
9. Alpha-actinin-4 and CLP36 protein deficiencies contribute to podocyte defects in multiple human glomerulopathies. Liu Z; Blattner SM; Tu Y; Tisherman R; Wang JH; Rastaldi MP; Kretzler M; Wu C J Biol Chem; 2011 Sep; 286(35):30795-30805. PubMed ID: 21680739 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis. Feng D; Kumar M; Muntel J; Gurley SB; Birrane G; Stillman IE; Ding L; Wang M; Ahmed S; Schlondorff J; Alper SL; Ferrante T; Marquez SL; Ng CF; Novak R; Ingber DE; Steen H; Pollak MR J Am Soc Nephrol; 2020 Jul; 31(7):1479-1495. PubMed ID: 32540856 [TBL] [Abstract][Full Text] [Related]
11. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis. Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926 [TBL] [Abstract][Full Text] [Related]
13. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome. Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878 [TBL] [Abstract][Full Text] [Related]
14. Mice with podocyte-specific overexpression of wild type alpha-actinin-4 are healthy controls for K256E-alpha-actinin-4 mutant transgenic mice. Michaud JL; Stitt-Cavanaugh E; Endlich N; Endlich K; De Repentigny Y; Kothary R; Kennedy CR Transgenic Res; 2010 Apr; 19(2):285-9. PubMed ID: 19585264 [TBL] [Abstract][Full Text] [Related]
15. Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases. Beeken M; Lindenmeyer MT; Blattner SM; Radón V; Oh J; Meyer TN; Hildebrand D; Schlüter H; Reinicke AT; Knop JH; Vivekanandan-Giri A; Münster S; Sachs M; Wiech T; Pennathur S; Cohen CD; Kretzler M; Stahl RA; Meyer-Schwesinger C J Am Soc Nephrol; 2014 Nov; 25(11):2511-25. PubMed ID: 24722446 [TBL] [Abstract][Full Text] [Related]
16. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases. Szabó T; Ambrus L; Zákány N; Balla G; Bíró T Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740 [TBL] [Abstract][Full Text] [Related]
17. α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function. Zhao X; Hsu KS; Lim JH; Bruggeman LA; Kao HY J Biol Chem; 2015 Jan; 290(1):338-49. PubMed ID: 25411248 [TBL] [Abstract][Full Text] [Related]